ISRCTN57157825已完成不适用
International Collaborative Ovarian Neoplasm studies (3): a trial of paclitaxel with carboplatin in the first-line treatment of ovarian cancer
Medical Research Council (MRC) (UK)0 个研究点目标入组 2,000 人开始时间: 2001年2月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Chemotherapy indicated
- •2. No previous chemotherapy or radiotherapy
- •3. No contraindication to chemotherapy
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
已完成
不适用
International Collaborative Ovarian Neoplasm studies (2): a trial of CAP versus carboplatin in advanced ovarian cancerCancerOvarian cancerISRCTN48215558Medical Research Council (MRC) (UK)2,000
已完成
不适用
International Collaborative Ovarian Neoplasm studies (1): A trial of adjuvant chemotherapy for early stage ovarian cancerOvarianCancerISRCTN11916376Medical Research Council (MRC) (UK)2,000
已完成
不适用
European Randomised Trial of Ovarian Cancer Screening IICancerISRCTN79217590Cancer Research UK (CRUK) (UK)
进行中（未招募）
不适用
The long-term impact on deaths and cost-effectiveness of screening for ovarian cancer using a blood test and ultrasoundTubo-ovarian cancerCancerOvarian cancerISRCTN22488978niversity College London (UK)202,638
尚未招募
不适用
Archipelago of Ovarian Cancer ResearchNL-OMON26124Dutch Cancer Society32,500